Katharinenhospital Innere Medizin
Stuttgart 70174
1 studies enrolling now · 2 studies all time
What they study most
Carcinoma, Non-Small-Cell Lung, Non-Muscle Invasive Bladder Neoplasms
Studies at this site
- A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Recruiting now
- A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer — Recruiting now